Terms: = Endocrine gland cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Prognosis
24 results:
1. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
[TBL] [Abstract] [Full Text] [Related]
3. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis.
Chen L; Zhang X; Zhang Q; Zhang T; Xie J; Wei W; Wang Y; Yu H; Zhou H
Front Immunol; 2022; 13():1022420. PubMed ID: 36275722
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of high mobility group A2 (hmga2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic hmga2 expression.
Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528
[TBL] [Abstract] [Full Text] [Related]
5. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic hmga2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract] [Full Text] [Related]
6. High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN.
Guo HH; Wang YZ; Zhang ZK; Li MZ; Tian XD; Yang YM
Exp Cell Res; 2020 Aug; 393(1):112088. PubMed ID: 32413362
[TBL] [Abstract] [Full Text] [Related]
7. OLR1 Promotes Pancreatic cancer Metastasis via Increased c-Myc Expression and Transcription of hmga2.
Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
[TBL] [Abstract] [Full Text] [Related]
8. MiR-497 inhibits cell proliferation and invasion ability by targeting hmga2 in pancreatic ductal adenocarcinoma.
Zhou ZG; Xu C; Dong Z; Wang YP; Duan JY; Yan CQ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):122-129. PubMed ID: 31957824
[TBL] [Abstract] [Full Text] [Related]
9. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract] [Full Text] [Related]
10. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract] [Full Text] [Related]
11. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Xi T; Zhang G
PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
[TBL] [Abstract] [Full Text] [Related]
12. A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian cancer.
Jin C; Xue Y; Li Y; Bu H; Yu H; Zhang T; Zhang Z; Yan S; Lu N; Kong B
Int J Gynecol Cancer; 2018 Jan; 28(1):51-58. PubMed ID: 28976449
[TBL] [Abstract] [Full Text] [Related]
13. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer.
Li XJ; Gangadaran P; Kalimuthu S; Oh JM; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC
Int J Cancer; 2016 Dec; 139(11):2583-92. PubMed ID: 27537102
[TBL] [Abstract] [Full Text] [Related]
14. SIRT6 Suppresses Pancreatic cancer through Control of Lin28b.
Kugel S; Sebastián C; Fitamant J; Ross KN; Saha SK; Jain E; Gladden A; Arora KS; Kato Y; Rivera MN; Ramaswamy S; Sadreyev RI; Goren A; Deshpande V; Bardeesy N; Mostoslavsky R
Cell; 2016 Jun; 165(6):1401-1415. PubMed ID: 27180906
[TBL] [Abstract] [Full Text] [Related]
15. Identification of key regulators of pancreatic cancer progression through multidimensional systems-level analysis.
Rajamani D; Bhasin MK
Genome Med; 2016 May; 8(1):38. PubMed ID: 27137215
[TBL] [Abstract] [Full Text] [Related]
16. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.
Yan L; Zhou J; Gao Y; Ghazal S; Lu L; Bellone S; Yang Y; Liu N; Zhao X; Santin AD; Taylor H; Huang Y
Oncogene; 2015 Jun; 34(23):3076-84. PubMed ID: 25088204
[TBL] [Abstract] [Full Text] [Related]
18. An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors.
Chieffi P; Chieffi S
Histol Histopathol; 2014 Aug; 29(8):999-1006. PubMed ID: 24627150
[TBL] [Abstract] [Full Text] [Related]
19. Shortening of the 3' untranslated region: an important mechanism leading to overexpression of hmga2 in serous ovarian cancer.
He X; Yang J; Zhang Q; Cui H; Zhang Y
Chin Med J (Engl); 2014; 127(3):494-9. PubMed ID: 24451956
[TBL] [Abstract] [Full Text] [Related]
20. High hmga2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer.
Califano D; Pignata S; Losito NS; Ottaiano A; Greggi S; De Simone V; Cecere S; Aiello C; Esposito F; Fusco A; Chiappetta G
J Cell Physiol; 2014 Jan; 229(1):53-9. PubMed ID: 23765903
[TBL] [Abstract] [Full Text] [Related]
[Next]
